ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources; 
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles. 

Embargoed until July 26, 4:00 p.m. ET:

Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes (JCO PO: Original Report) 
Albert C. Koong, et al.
Request this article

Embargoed until July 25, 4:00 p.m. ET:

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis (JCO: Original Report) 
Philip McCarthy, et al.
Request this article

Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis (JCO: Original Report) 
Danxia Yu, et al.  
Request this article 

Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia (JGO: Original Report)
David Kerr, et al.
Request this article

Embargoed until July 24, 4:00 p.m. ET:

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute (JCO: ASCO Special Article) 
Blase Polite, et al.
Request this article

Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop (JCO: Special Article) 
Jeremy Warner, et al.
Request this article

Quality Improvement in the Era of Big Data (JCO: Editorial) 
Michael Hassett, et al.
Request this article

Current Treatment Landscape of Advanced Papillary Renal Cancer (JCO: Editorial) 
Neeraj Agarwal, et al.
Request this article

Embargoed until July 21, 4:00 p.m. ET:

Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study (JCO CCI: Original Report) 
Amar Kishan, et al.
Request this article

Embargoed until July 20, 4:00 p.m. ET:

Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer (JCO: Original Report) 
Katherine Reeder-Hayes, et al.
Request this article

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas (JCO: Original Report) 
Uri Tabori, et al. 
Request this article

Embargoed until July 19, 4:00 p.m. ET:

End-of-Life Services Among Patients With Cancer: Evidence From Cancer Registry Records Linked With Commercial Health Insurance Claims (JOP: Original Contribution) 
Cara McDermott, et al.
Request this article

Embargoed until July 18, 4:00 p.m. ET:

Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in Neuroblastoma (JCO PO: Original Report)
Federica Saletta, et al.
Request this article

Embargoed until July 17, 4:00 p.m. ET:

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib (JCO: Original Report) 
Cameron Turtle, et al.
Request this article

Changing the Natural History of Non–Small-Cell Lung Cancer Through Upfront Programmed Death Protein 1/Programmed Death-Ligand 1 Blockade (JCO: Editorial) 
Daniel Tan, et al.
Request this article

Breast Cancer Beliefs as Potential Targets for Breast Cancer Awareness Efforts to Decrease Late-Stage Presentation in Uganda (JGO: Original Report) 
John Scheel, et al.
Request this article

Embargoed until July 14, 4:00 p.m. ET:

Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women (JCO: Original Report) 
Marie-Christine Boutron-Ruault, et al.
Request this article

Embargoed until July 13, 4:00 p.m. ET:

Redelivering Information to Young Adults and Adolescents Treated for Cancer During Childhood (JOP: Editorial) 
Judith Landman-Parker, et al.
Request this article

Embargoed until July 12, 4:00 p.m. ET:

Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study (JCO: Original Report) 
Amit Pursnani, et al.
Request this article

Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care (JCO: Original Report) 
Lauren Wallner, et al.
Request this article

In Accordance With Our Best Estimates (JCO: Editorial) 
Michael Bookman, et al.
Request this article

Embargo Information

The embargo date and time of a journal article coincides with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year, and may affect broader ASCO media privileges as well.  Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.